Safety and Efficacy of NK510 to Treat Gastric Cancer and Colorectal Cancer

NCT07166263 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

NOT_YET_RECRUITING

Status

15

Enrollment

INDUSTRY

Sponsor class

Conditions

Gastric Cancer (GC)
Colorectal Cancer

Interventions

DRUG: NK510
DRUG: NK510

Sponsor

Base Therapeutics (Shanghai) Co., Ltd.